captopril has been researched along with milrinone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Muir, AL; Nolan, J | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Casanegra, P; Chamorro, G; Corbalán, R; Jalil, J; Valenzuela, P | 1 |
| Katz, S; LeJemtel, TH; Scortichini, D | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| Chadwick, B; Gumbardo, D; LeJemtel, TH; Rutman, HI; Sonnenblick, EH | 1 |
| Chadwick, B; Feld, H; LeJemtel, TH; Mancini, D; Maskin, CS; Sinoway, L | 1 |
| Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
1 review(s) available for captopril and milrinone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for captopril and milrinone
| Article | Year |
|---|---|
Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
Topics: Aged; Captopril; Cardiotonic Agents; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Pyridones; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Time Factors | 1990 |
Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance.
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Milrinone; Oxygen Consumption; Physical Exertion; Pyridones; Time Factors | 1986 |
12 other study(ies) available for captopril and milrinone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Modulation of venous tone in heart failure.
Topics: Captopril; Felodipine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Vasodilation; Vasodilator Agents | 1991 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
Topics: Captopril; Cardiac Output; Heart Failure; Humans; Lactates; Lactic Acid; Milrinone; Muscles; Phosphodiesterase Inhibitors; Physical Exertion; Pyridones; Regional Blood Flow; Thermodilution; Xenon Radioisotopes | 1988 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Milrinone; Proline; Pyridones; Renal Circulation; Time Factors | 1985 |
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents | 1994 |